Fig. 7
From: Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
SKL2001 reversed the effects of Sevoflurane on proliferation and apoptosis of QBC939 cells. A. CCK-8 assays were used to evaluate the cell proliferation of QBC939 cells; B-C. Flow cytometry were used to evaluate the apoptosis of QBC939 cells; D-F. Analysis of Bax and Bcl2 protein and mRNA expression in QBC939 cells by western blotting and RT-qPCR; G-J. Transwell assays were used to evaluate migration (F and G) and invasion (H and I) of QBC939 cells. Magnification: ×200. **p < 0.01 vs. control group; ##p < 0.01 vs. Sevoflurane treatment group